Skip Menus
Logo of the Montréal Heart Institute
Documentation Centre  |  ÉPIC Center  |  ICM Foundation  |  MHICC  |  DPC   
 |  Home  |  Site Map  |  Search  |  Contact Us  |  Français   
 Print
 Send to a friend
 Big  |  Small
A surgeon performing surgery
|  Profile of the Institute
|  Patients and Visitors
|  Professionals and Partners
|  News
* Departments and medical services
 Medicine
 Electrophysiology
 Team
 Perspectives
 Volume of activities
 Adult Congenital Heart Centre
 Pharmacy
* Research
* Teaching
* Prevention
* Nursing
* Client Services
* Human Resources
* Administrative Services

Electrophysiology in perspective


Electrophysiology around the world

Clinical cardiac electrophyisiology developed at lightening speed thanks to incredible technological evolution, among other things. This medical specialty led to a better understanding of the substrates responsible for arrhythmias and to the evolution of the therapeutic measures used to treat these disorders. Electrophysiology literally exploded, opening avenues for treatment that seemed unthinkable a few years ago.

Think of the new stimulation technologies, to implantable defibrillators and 3D mapping systems. All of this leads us to believe that we are only at the beginning of a period of development that will last for several years.

Members of the electrophyisiology department have contributed to this evolution. Catheter ablation has been available for treating arrhythmias for more than 15 years. Various members of the department were pioneers, both locally and internationally, in the development of this type of treatment. Still today, members contribute to the development and fine-tuning of cryoablation, a technology linked to catheter ablation.

Electrophysiology in Québec

Only four centres in Québec perform cardiac catheter ablations.

Electrophyisiology at the MHI

The MHI is still the leader when in comes to the latest electrophysiology treatment options. The speed at which technological advancements have been made over the past few years have rendered them more accessible. In fact, with catheter ablation, certain arrhythmic disorders can be completely corrected. In addition, implantable defibrillators have proven effective in secondary, and even primary prevention of sudden death. Progress such as this has led our patients and the cardiologists who refer them to our institution to have high expectations.

The need for pacemakers continues to increase as the population ages and because those who had pacemakers implanted years ago have lived longer than expected. We must plan for having to replace pacemakers. The prevalence of cardiac diseases is on the rise, but the perfecting of electrophysiological techniques, and the fine-tuning of medical equipment and of the skills of the teams of professionals have contributed greatly to increased demand for services.

It's within this context that the Institute has become a hospital renowned for its work in cardiology and cardiac surgery.

The MHI follows more than 4,800 patients with pacemakers and 800 patients with defibrillators. In 2002-2003, this translated into 3,600 clinic appointments for pacemaker patients and 1,136 visits for defibrillator patients. In addition, the medical team conducted more than 3,000 follow-up visits and new consultations for patients referred by fellow cardiologists at the Institute or from other regions of Québec.

 © Montréal Heart Institute - 2009